Sørensen M, Nowak P, Nielsen H. "一种【停用,肽序重复,请询 C4X-201419】endo-9a-Pro-西曲瑞克的合成方法" [P]. European Patent, EP 3411675 A1, 2024-02-24.
Lee S K, Patel M V, Davis P L. "Method for the Synthesis of 【肽序重复停用见C4X-201419】endo-9a-Pro-Cetrorelix" [P]. US Patent, US 10566583 B2, 2023-08-14.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用,肽序重复,请询 C4X-201419】endo-9a-Pro-西曲瑞克 in Pharmaceutical Formulations". Talanta, 2014, 1849, (3), 7699-7724.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用,肽序重复,请询 C4X-201419】endo-9a-Pro-西曲瑞克 as an Impurity". Food Chem., 2024, 604, (11), 6789-6802.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 【肽序重复停用见C4X-201419】endo-9a-Pro-Cetrorelix Using HRMS and NMR". Chemosphere, 2018, 349, (2), 3406-3426.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 【停用,肽序重复,请询 C4X-201419】endo-9a-Pro-西曲瑞克 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2023, 2019, (12), 5217-5235.